These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6428312)

  • 1. Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.
    Angehrn P; Hall MJ; Lloyd WJ; Westmacott D
    Antimicrob Agents Chemother; 1984 May; 25(5):607-11. PubMed ID: 6428312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocardicin A, a new monocyclic beta-lactam antibiotic III. In vitro evaluation.
    Nishida M; Mine Y; Nonoyama S; Kojo H
    J Antibiot (Tokyo); 1977 Nov; 30(11):917-25. PubMed ID: 412823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorocardicin, a monocyclic beta-lactam from a Streptomyces sp. I. Discovery, production and biological activities.
    Nisbet LJ; Mehta RJ; Oh Y; Pan CH; Phelen CG; Polansky MJ; Shearer MC; Giovenella AJ; Grappel SF
    J Antibiot (Tokyo); 1985 Feb; 38(2):133-8. PubMed ID: 3922933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the in vitro activity of some antimicrobial agents against selected gram-negative bacteria by EDTA-tromethamine.
    Farca AM; Nebbia P; Re G
    Vet Res Commun; 1993; 17(2):77-84. PubMed ID: 8212526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocardicin A, a new monocyclic beta-lactam antibiotic IV. Factors influencing the in vitro activity of Nocardicin A.
    Kojo H; Mine Y; Nishida M
    J Antibiot (Tokyo); 1977 Nov; 30(11):926-31. PubMed ID: 412824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocardicin A, a new monocyclic beta-lactam antibiotic V. In vivo evaluation.
    Mine Y; Nonoyama S; Kojo H; Fukada S; Nishida M
    J Antibiot (Tokyo); 1977 Nov; 30(11):932-7. PubMed ID: 338567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.
    Owens RC; Banevicius MA; Nicolau DP; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2586-8. PubMed ID: 9371376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial properties of alafosfalin combined with cephalexin.
    Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Lloyd WJ; Nisbet LJ; Ringrose PS; Westmacott D
    Antimicrob Agents Chemother; 1981 Oct; 20(4):470-6. PubMed ID: 7044291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
    Kurtz TO; Winston DJ; Bruckner DA; Martin WJ
    Antimicrob Agents Chemother; 1981 Aug; 20(2):239-43. PubMed ID: 6792982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with beta-lactams.
    Maruyama HB; Arisawa M; Sawada T
    Antimicrob Agents Chemother; 1979 Oct; 16(4):444-51. PubMed ID: 518073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin synergism with beta-lactam antibiotics against selected nosocomial pathogens.
    Gombert ME; Aulicino TM
    J Antimicrob Chemother; 1986 Mar; 17(3):323-6. PubMed ID: 3700292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides.
    Allen JG; Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Nisbet LJ; Ringrose PS
    Antimicrob Agents Chemother; 1979 May; 15(5):684-95. PubMed ID: 43113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    Eur J Clin Microbiol; 1987 Aug; 6(4):460-6. PubMed ID: 3117535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem.
    Di Modugno E; Broggio R; Erbetti I; Lowther J
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2742-8. PubMed ID: 9420050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.
    Critchley IA; Sahm DF; Kelly LJ; Karlowsky JA
    Chemotherapy; 2003 May; 49(1-2):44-8. PubMed ID: 12714810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.
    Buesing MA; Jorgensen JH
    Antimicrob Agents Chemother; 1984 Feb; 25(2):283-5. PubMed ID: 6538773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa.
    Song W; Woo HJ; Kim JS; Lee KM
    Int J Antimicrob Agents; 2003 Jan; 21(1):8-12. PubMed ID: 12507832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity and mechanism of action of phosphonopeptides based on aminomethylphosphonic acid.
    Atherton FR; Hall MJ; Hassall CH; Lambert RW; Lloyd WJ; Ringrose PS; Westmacott D
    Antimicrob Agents Chemother; 1982 Oct; 22(4):571-8. PubMed ID: 6758686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.